Doris O'Brien is a retired college Speech teacher and banker. She has published two books of humor (Up or Down With Women's Liberation and Humor Me a Little) and for many years contributed light verse to the Pepper 'n Salt column of the Wall Street Journal. She is an avid writer of letters to the editors.
Doris celebrated her 50th wedding anniversary in the same year she welcomed her first grandchild. She now lives in Pasadena with a great view of the San Gabriel mountains — and the annual Tournament of Roses Parade.
She can be reached by e-mail: witsendob at (@) gmail.com
Jo Freeman: With the 116th Congress the Party Gap has Become a Party Chasm
Jo Freeman writes: While many have greatly lauded this great leap upward over the 112 women who were M.C.s during 115th Congress, few have noted that this gain was almost entirely among Democrats. Of the 36 women elected to the House for the first time, only one is a Republican. Of the 3 new Senators, only one is a Republican. Women are now 25 percent of both houses of Congress, but not of both parties. Women are over one-third of the Democratic Caucus in both houses (36% and 39%), 15 percent of Republicans in the Senate, and only 8 percent of Republicans in the House. more »
Skydivers Don’t Need Parachutes, Scientists Don’t Actually Find: Be wary of parachute journalism. And also parachute research.
Beyond the general critique of careless interpretations of seemingly sexy study findings, the authors make a subtler point about clinical trials. They screened 92 potential participants for the study, but only 23 were eligible and willing to participate. The authors suggest that this resembles common practice in clinical trials, where a small fraction of the patients screened are included. They add that prior research shows participants who might stand to gain the most from the experimental treatment often are less likely to be included in clinical trials. more »
Stateline: Some Drug Users in Western US Seek Out Deadly Fentanyl. Here’s Why.
In a series of interviews with heroin users in Rhode Island in 2017, Brown University researchers reported that users “described fentanyl as unpleasant, potentially deadly, and to be avoided.” They concluded that demand for the deadly contaminant was low and that its presence in the drug supply was “generating user interest in effective risk mitigation strategies, including treatment.” But in San Francisco’s gritty Tenderloin district, where fentanyl was only rarely seen until last year, drug users tell a starkly different story. For many of them, fentanyl is a high-value drug that, if used carefully, can prevent dope sickness and deliver a strong high for a fraction of the price of heroin.
Amber Sheldon, right, greets a frequent client at the harm reduction program at Glide in San Francisco. The program offers clean syringes, drug tes… more »
Iberia: Reminders that Power Can Vanish and What Turns Out to Be Important is How You Can Live Today
Sonya Zalubowski writes: One of the most thrilling moments was our visit to the Alcazar in Segovia, the castle with foundations that date to Roman times, where Isabella and Ferdinand reigned in the 15th century. We stood in the very throne room where Christopher Columbus once knelt before her. The people are surrounded by remnants of a succession of cultures ranging all the way back to prehistoric to Roman, Visigoth and Moorish, to the kings and queens whose rule dominated Europe as they sent out Portuguese and Spanish explorers, to 20th-century despots and finally present day governments more »
